Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04433208 · ClinicalTrials.gov registry record · NA
Dietary Supplement With and Without a Probiotic
A NA study, sponsored by Prolacta Bioscience.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT04433208 is a NA study that has completed, run by Prolacta Bioscience. The registered enrollment target is 62 participants.
The verdict
NCT04433208, a NA study, has completed, sponsored by Prolacta Bioscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.
Interventions
- DIETARY_SUPPLEMENT Probiotic
- DIETARY_SUPPLEMENT Complex oligosaccharide
- OTHER PPI
- OTHER H2 Blocker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-03-13 |
| Est. Completion | 2020-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04433208
The ClinicalTrials.gov registry entry for NCT04433208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prolacta Bioscience, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Probiotic is the first listed.
NCT04433208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04433208 about?
NCT04433208 is a clinical study titled "Dietary Supplement With and Without a Probiotic". Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.
What is the current status of trial NCT04433208?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2020-03-13. Estimated completion is 2020-12-02.
What interventions are being tested in trial NCT04433208?
The interventions under investigation include: Probiotic (DIETARY_SUPPLEMENT), Complex oligosaccharide (DIETARY_SUPPLEMENT), PPI (OTHER), H2 Blocker (OTHER).
Who is sponsoring clinical trial NCT04433208?
This trial is sponsored by Prolacta Bioscience, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.